Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Type 2 Diabetes Patients Reach Target Glycemic Control Faster Using IDegLira than Either Insulin Degludec or Liraglutide Given Alone.
Clin Drug Investig. 2016 Apr;36(4):293-303. doi: 10.1007/s40261-016-0376-0.
Clin Drug Investig. 2016.
PMID: 26894800
Free PMC article.
Safety and efficacy of insulin degludec/liraglutide (IDegLira) added to sulphonylurea alone or to sulphonylurea and metformin in insulin-naïve people with Type 2 diabetes: the DUAL IV trial.
Rodbard HW, Bode BW, Harris SB, Rose L, Lehmann L, Jarlov H, Thurman J; Dual Action of Liraglutide and insulin degludec (DUAL) IV trial investigators.
Rodbard HW, et al. Among authors: jarlov h.
Diabet Med. 2017 Feb;34(2):189-196. doi: 10.1111/dme.13256. Epub 2016 Oct 7.
Diabet Med. 2017.
PMID: 27589252
Free PMC article.
Clinical Trial.
Item in Clipboard
Rates of hypoglycaemia are lower in patients treated with insulin degludec/liraglutide (IDegLira) than with IDeg or insulin glargine, regardless of the hypoglycaemia definition used.
Norwood P, Chen R, Jaeckel E, Lingvay I, Jarlov H, Lehmann L, Heller S.
Norwood P, et al. Among authors: jarlov h.
Diabetes Obes Metab. 2017 Nov;19(11):1562-1569. doi: 10.1111/dom.12972. Epub 2017 Jul 10.
Diabetes Obes Metab. 2017.
PMID: 28417535
Free PMC article.
Item in Clipboard
ARISE-a prospective, non-interventional, single-arm study assessing clinical parameters associated with the use of insulin degludec/insulin aspart in patients with type 2 diabetes in real-world settings: rationale and design.
Fulcher GR, Jarlov H, Piltoft JS, Singh KP, Liu L, Mohamed M, Nicodemus NA Jr, Al-Jaser SJ, Kok A.
Fulcher GR, et al. Among authors: jarlov h.
Endocrine. 2021 Dec;74(3):530-537. doi: 10.1007/s12020-021-02887-8. Epub 2021 Oct 12.
Endocrine. 2021.
PMID: 34637072
Free PMC article.
Item in Clipboard
Correction: ARISE-a prospective, non-interventional, single-arm study assessing clinical parameters associated with the use of insulin degludec/insulin aspart in patients with type 2 diabetes in realworld settings: rationale and design.
Fulcher GR, Jarlov H, Piltoft JS, Singh KP, Liu L, Mohamed M, Nicodemus NA Jr, Al-Jaser SJ, Kok A.
Fulcher GR, et al. Among authors: jarlov h.
Endocrine. 2022 Mar;75(3):964. doi: 10.1007/s12020-021-02956-y.
Endocrine. 2022.
PMID: 34919203
Free PMC article.
No abstract available.
Item in Clipboard
A novel nonsense mutation in PAX9 is associated with marked variability in number of missing teeth.
Hansen L, Kreiborg S, Jarlov H, Niebuhr E, Eiberg H.
Hansen L, et al. Among authors: jarlov h.
Eur J Oral Sci. 2007 Aug;115(4):330-3. doi: 10.1111/j.1600-0722.2007.00457.x.
Eur J Oral Sci. 2007.
PMID: 17697174
Item in Clipboard
Cite
Cite